Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

On CNBC's “Mad Money Lightning Round,” on Thursday, Jim Cramer said Recursion Pharmaceuticals (NASDAQ: RXRX) has been “horrendous” and he does not like to recommend horrendous stocks. On the earnings ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Seattle Mayor-elect Katie Wilson announced her full transition team Wednesday, naming 60 local experts, organizers and advocates as she prepares to take over from outgoing Mayor Bruce Harrell in ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Seattle Mayor-elect Katie Wilson named a director and four co-chairs of her transition team Wednesday, marking her first significant decision since her election victory was confirmed last week. The ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

As New York City Mayor-elect Zohran Mamdani's team is taking shape, tens of thousands of people have applied for jobs in the new administration, a top official with the transition says. Maria ...

If you’re used to hearing much more about how to cover your grays than how to transition to gray hair, you’re not alone. But as some of our favorite celebrities (Diane Keaton, Andie MacDowell, and ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

You can stop looking for glitches in the Matrix—it’s finally been proven that our universe is not merely a simulation running on some powerful alien civilization’s supercomputer. An international team ...